FeesSafety
Pluang+

Waters launches BD FACSDiscover A7, advancing flow cytometry for cancer and disease research.

Market News
14 Sep 2026
PRNewsWire
View Source
Bullish
Waters launches BD FACSDiscover A7, advancing flow cytometry for cancer and disease research.

Waters Corporation has launched the BD FACSDiscover A7 Cell Analyzer, a new flow cytometry device that offers high spectral resolution and sensitivity with advanced standardization features. It enables researchers to analyze over 50 cell parameters consistently, improving reproducibility and confidence in data across labs. The device integrates BD SpectralFX and FACSTruQ technologies for automated calibration and quality control, speeding up research in immunology and drug development. Now available globally, it aims to make advanced cell analysis more accessible to academia, pharma, and contract research organizations.

Waters Corporation's launch of the BD FACSDiscover A7 Cell Analyzer comes as the health sector on Pluang shows mixed activity. For readers following health stocks, here is Pluang's market snapshot as of Sep 14, 2026 18:52 WIB: out of 91 priced US health-sector stocks, 50 rose and 28 fell. Notable movers include Medtronic PLC (MDT) up 2.55% at USD 93.28, AbCellera Biologics Inc (ABCL) down 2.30% at USD 10.64, and Twist Bioscience Corp (TWST) down 1.93% at USD 124.77.

More News

Over $815M in crypto liquidations hit as Bitcoin drops below $80K, Ether near $2,350

Over $815M in crypto liquidations hit as Bitcoin drops below $80K, Ether near $2,350

A major crypto market deleveraging saw over 118,000 traders liquidated, with $815-$821 million wiped from leveraged positions, mainly longs. Bitcoin fell below $80,000 and Ether approached $2,350, signaling a market correction and reduced confidence ...

Market News
Bearish
4 hours ago
Pumitamig plus docetaxel shows 36.7% response in advanced NSCLC after immunotherapy failure

Pumitamig plus docetaxel shows 36.7% response in advanced NSCLC after immunotherapy failure

BioNTech and Bristol Myers Squibb reported promising Phase 2 results for pumitamig combined with docetaxel in advanced non-small cell lung cancer (NSCLC) patients who progressed after immunotherapy plus chemotherapy. The treatment showed a confirmed ...

Company Fundamentals
Bullish
4 hours ago
US households' 1-year inflation expectations rise to 4.7% ahead of Fed policy meeting

US households' 1-year inflation expectations rise to 4.7% ahead of Fed policy meeting

US households' inflation expectations for the next year increased to 4.7% in October, the highest since May, while long-term expectations also rose. Consumer sentiment remained nearly unchanged, with mixed shifts in economic conditions and expectatio...

Market News
Neutral
4 hours ago
Tether freezes 2.21M USDT linked to CoinDCX after 15.99M USDT suspicious transfers detected

Tether freezes 2.21M USDT linked to CoinDCX after 15.99M USDT suspicious transfers detected

Tether has frozen 2,212,850.3 USDT across nine addresses connected to a security incident involving CoinDCX, following the detection of roughly 15.99 million USDT in unusual transfers. The investigation began after identifying these large suspicious ...

Market News
Bearish
4 hours ago
90% of Pump.fun contracts reverse-engineering done, full open source release urged by Oct 25

90% of Pump.fun contracts reverse-engineering done, full open source release urged by Oct 25

Andreessen Horowitz founder Shaw announced that 90% of the reverse-engineering work on all Pump.fun smart contracts is complete, with the remaining 10% expected to finish by October 25. Shaw emphasized the importance of making all contract code open ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App